Georgia-Pacific Avoids Paying Former Employees Compensation for Asbestos Exposure
January 30, 2024
Compac Quartz, Inc.
February 21, 2024
Artificial Intelligence is becoming more popular in our everyday lives. AI is on our search engines, our phones, our vehicles, and even our health care systems. Could AI help diagnose and treat cancers like mesothelioma?
The National Institutes of Health (NIH) states that “AI applications in oncology include risk assessment, early diagnosis, patient prognosis estimation, and treatment selection based on deep knowledge.”
Cancer is a leading cause of morbidity and mortality worldwide. While progress has been made in the diagnosis, prognosis, and treatment of cancer patients, individualized care is a challenge. AI could help diagnose cancer and recognize anomalies in scans that doctors may miss.
According to Cancer Research UK, there are five things needed in the healthcare field to make AI cancer diagnosis standard.
The first is support for AI technology in the workforce. Hospitals and treatment centers will need AI specialists to setup and run the equipment and training and development opportunities for medical staff.
The second is infrastructure. AI systems need digital data in order to work. Radiology is mostly already fully digitized, which put in a good position to embrace AI. Most pathologists, however, still look at samples under a microscope.
The third is confident leaders. Healthcare leaders must see the potential of AI tools and be ready with solutions to impending issues like funding and manpower.
The fourth in equality. AI can help anyone at risk of cancer, not just certain sections of the population. AI tools should be trained on anyone regardless of an individual’s ethnicity, sex, or other characteristics.
The fifth is to maintain public trust. Technological advances, such as AI, can be abandoned quickly if the public does not think it is trustworthy.
AI has emerged as a promising option for improving healthcare accuracy and patient outcomes. AI has the potential to improve the diagnosis, prognosis, and quality of life of patients with mesothelioma.